How ESOPs Are Taxed in India

Employee Stock Option Plans have become a standard part of compensation at Indian startups and technology companies, and increasingly at larger firms too. They are powerful — a way to share in the upside of the company you help build. But they are also one of the most misunderstood pieces of an employee's tax life. People sign their grant letters without realising that ESOPs are taxed at two completely separate moments, under two completely different heads of income, and that a poorly timed exercise can create a tax bill on shares they cannot even sell yet. This guide explains exactly how ESOPs are taxed in India for FY 2025-26 — the perquisite tax at exercise, the capital gains tax at sale, the startup deferral relief, and a full worked example that ties it all together.

The Four Stages of an ESOP — and Which Are Taxable

An ESOP moves through four stages:

1. Grant — the company gives you the option to buy a certain number of shares at a fixed price (the exercise or strike price) in the future. Not taxable.
2. Vesting — over time, your right to exercise becomes real, usually on a schedule (for example, 25% per year over four years). Not taxable.
3. Exercise — you choose to convert your vested options into actual shares by paying the exercise price. Taxable as a salary perquisite.
4. Sale — you eventually sell the shares you own. Taxable as capital gains.

The two taxable events are exercise and sale. Grant and vesting create no tax. This is the single most important thing to internalise: you have a tax liability the moment you exercise, even if you do not sell, and another when you finally sell.

Stage One: Tax at Exercise (Perquisite)

When you exercise your options, you usually pay an exercise price far below what the share is actually worth. That bargain element is treated as a benefit your employer has given you — a perquisite — and is taxed as part of your salary income at your slab rate.

The taxable perquisite is:

Fair Market Value (FMV) of the share on the exercise date − Exercise price paid

multiplied by the number of shares exercised.

• For listed shares, the FMV is the market price on the exercise date.
• For unlisted shares (typical for startups), the FMV is determined by a merchant banker's valuation as on a specified date, per the prescribed rules.

Your employer deducts TDS on this perquisite as part of your salary in the month of exercise, and it appears in your Form 16. This is where the cash crunch bites: you may owe tax on a paper gain while holding shares you cannot sell — especially in a private startup with no liquidity. The TDS on this perquisite is part of your salary TDS, covered in TDS on salary explained.

Stage Two: Tax at Sale (Capital Gains)

When you later sell the shares, you pay capital gains tax — but only on the gain above what was already taxed at exercise. The law sets your cost of acquisition for capital gains as the FMV that was taxed as a perquisite at exercise. So:

Capital gain = Sale price − FMV on exercise date (the amount already taxed as perquisite)

This is how the system avoids double taxation: the appreciation up to exercise was taxed as salary, and only the appreciation after exercise is taxed as capital gains.

The rate depends on whether the shares are listed and how long you held them (counted from the exercise date, when you acquired the shares). For FY 2025-26:

Share Type	Holding Period for Long-Term	Long-Term Rate	Short-Term Rate
Listed equity shares (STT paid)	More than 12 months	12.5% above ₹1.25 lakh exempt	20%
Unlisted shares	More than 24 months	12.5%	Slab rate

For listed shares, long-term gains above the ₹1.25 lakh annual exemption are taxed at 12.5%, and short-term gains at 20%. For unlisted shares, long-term gains (held over 24 months) are taxed at 12.5%, and short-term gains are added to income and taxed at your slab rate. The mechanics mirror those in our capital gains tax in India guide.

The Startup Deferral Relief

The "tax at exercise on illiquid shares" problem is real and painful, especially for startup employees. To address it, the law allows eligible startup employees to defer the perquisite tax due at exercise.

If your employer is a startup recognised under the relevant government framework, you do not have to pay the perquisite tax in the year of exercise. Instead, the tax (and the TDS) can be deferred until the earliest of:

• About five years from the end of the financial year in which you exercised, or
• The date you sell the shares, or
• The date you leave the company.

This is a genuine relief: it lets you exercise and hold without an immediate tax bill on shares you cannot monetise. Note three things — the deferral applies only to the perquisite tax at exercise, not to capital gains at sale; the perquisite amount itself is still computed using the FMV on the original exercise date; and the relief is limited to employees of eligible startups, so most employees of larger companies do not qualify and must pay the perquisite tax in the year of exercise.

A Full Worked Example

Let us follow Neha, an early employee at a Bengaluru startup, through the full ESOP life cycle. Assume the startup is not an eligible startup for deferral, so she pays perquisite tax at exercise. She is in the 30% slab.

Grant: 10,000 options at an exercise price of ₹50 per share. (No tax.)

Vesting: Vests over four years. (No tax.)

Exercise: After full vesting, Neha exercises all 10,000 options. The merchant-banker FMV on the exercise date is ₹300 per share. She pays the exercise price of ₹50 × 10,000 = ₹5,00,000 to acquire the shares.

Perquisite at exercise: (FMV ₹300 − Exercise price ₹50) × 10,000 = ₹250 × 10,000 = ₹25,00,000.

This ₹25,00,000 is added to her salary and taxed at her slab rate. At 30% plus 4% cess, the tax is roughly ₹7,80,000, deducted as TDS by her employer. Neha pays this even though she has not sold a single share — the classic ESOP cash crunch.

Sale: Two years later, the startup gets acquired and Neha sells all 10,000 shares at ₹700 per share.

Capital gain at sale: Sale price ₹700 − Cost (FMV at exercise) ₹300 = ₹400 per share × 10,000 = ₹40,00,000.

These are unlisted shares held for more than 24 months (from exercise to sale), so the gain is long-term, taxed at 12.5%: ₹40,00,000 × 12.5% = ₹5,00,000 (plus applicable surcharge and cess).

Total tax across both stages:

Stage	Taxable Amount	Head	Approx Tax
Exercise	₹25,00,000	Salary perquisite (30% slab)	~₹7,80,000
Sale	₹40,00,000	LTCG on unlisted shares (12.5%)	~₹5,00,000

Notice that the ₹300 FMV taxed as perquisite at exercise is not taxed again at sale — only the further appreciation from ₹300 to ₹700 is. The two stages tax two different slices of the total gain from ₹50 to ₹700. You can estimate the salary-side tax with the income tax calculator and the capital gains side using the principles in our capital gains guide.

ESOPs, RSUs and ESPPs: How They Differ

"ESOP" is often used loosely to cover several different equity-compensation instruments, and their tax timing differs slightly even though the two-stage salary-then-capital-gains structure is broadly the same:

ESOPs (stock options): You receive the right to buy shares at a fixed exercise price. The perquisite is taxed when you exercise (FMV on exercise date minus the exercise price). This is the classic case described above.

RSUs (Restricted Stock Units): You are granted units that convert into actual shares on vesting, usually without paying anything. Because there is no exercise price to pay, the entire FMV of the shares on the vesting date is taxed as a perquisite. RSUs are common at large listed multinationals. The capital gains stage works the same way — cost base is the FMV taxed at vesting, holding period runs from vesting.

ESPPs (Employee Stock Purchase Plans): You buy shares, often at a discount to market price, through payroll deductions. The discount you receive is taxed as a perquisite, and subsequent gains are capital gains.

Instrument	Perquisite taxed at	Perquisite amount
ESOP	Exercise	FMV at exercise − exercise price
RSU	Vesting	Full FMV at vesting
ESPP	Purchase	FMV at purchase − discounted price paid

The key difference is when the salary-side tax triggers — exercise for ESOPs, vesting for RSUs, purchase for ESPPs — but in every case it is taxed as a salary perquisite and the FMV taxed becomes your capital gains cost base.

How the Perquisite Interacts with the Rest of Your Salary

Because the ESOP perquisite is added to your salary income, it stacks on top of your regular pay for the year and can have knock-on effects:

• It can push you into a higher slab or trigger surcharge. A large perquisite in one year — say ₹25 lakh — added to a ₹20 lakh salary can take your total income well past slab and surcharge thresholds, raising your effective rate. Timing your exercise across financial years, where you have the choice, can sometimes soften this.
• It increases your TDS sharply in the exercise month. Your employer deducts TDS on the perquisite as part of salary, so your take-home in the exercise month can drop dramatically. Plan your cash flow for that month.
• It may create an advance tax obligation. If your employer's TDS does not fully cover the perquisite — or if you also have capital gains on sale — you may owe advance tax. The perquisite itself is usually handled through salary TDS, but the capital gains on sale almost never are, so the sale year often needs advance tax.

This salary-side stacking is why the choice of tax regime in an exercise year deserves a fresh look — a one-off spike in income can change which regime is cheaper for that year.

A Note on Cross-Border ESOPs

Many Indian employees hold ESOPs or RSUs of foreign parent companies. The same two-stage structure applies — perquisite at exercise (or at vesting for RSUs) and capital gains at sale. But foreign shares are unlisted in the Indian sense for rate purposes, foreign tax may be withheld, and you may need to disclose foreign assets in the Schedule FA of your return. Foreign-held shares add reporting complexity, and tax credit for any foreign tax paid may be available under a double-taxation treaty. This is an area where professional help genuinely pays for itself.

Common Mistakes

Thinking ESOPs are taxed only when you sell. The perquisite tax at exercise is the surprise that catches most people. You owe tax the moment you exercise, regardless of whether you sell. Plan for the cash to pay it.

Exercising without considering liquidity. Exercising vested options in an illiquid private company triggers perquisite tax with no way to sell shares to fund it. Unless you qualify for the startup deferral, weigh whether to exercise now or wait for a liquidity event. The decision is as much about cash flow as taxes.

Forgetting that FMV at exercise is the capital gains cost base. When computing capital gains at sale, people sometimes use the original exercise price as the cost, overstating the gain. The cost is the FMV already taxed at exercise, not the price you paid.

Miscounting the holding period. The holding period for capital gains runs from the exercise date (when you acquired the shares), not the grant or vesting date. Getting this wrong flips a gain between short-term and long-term and changes the rate.

Ignoring the startup deferral when eligible. Employees of eligible startups sometimes pay perquisite tax at exercise out of habit, unaware they could have deferred it for years until a liquidity event. If your employer qualifies, ask about the deferral before exercising.

Overlooking foreign-share disclosure. Holding RSUs or ESOPs of a foreign parent triggers foreign asset reporting obligations. Omitting Schedule FA disclosures can lead to serious consequences, separate from the tax itself.

What to Do Next

1. Read your ESOP grant and exercise documents carefully and note the exercise price and the FMV mechanism — these two numbers drive the entire tax outcome.
2. Before exercising, estimate the perquisite tax (FMV minus exercise price, at your slab rate) and make sure you have the cash to pay the TDS, using the income tax calculator.
3. Check whether your employer is an eligible startup that lets you defer the perquisite tax — if so, factor the deferral into your timing.
4. When you sell, compute capital gains as sale price minus the FMV taxed at exercise, apply the correct holding period from the exercise date, and use the rates for listed or unlisted shares as relevant.
5. Keep your grant letters, exercise statements, FMV valuations and broker contract notes organised with a tax document checklist, and fold the timing into your broader tax planning.

ESOPs can be life-changing wealth, but their tax treatment punishes the unprepared. Remember the two taxing events — perquisite at exercise, capital gains at sale — keep the FMV at exercise as your cost base, use the startup deferral if you qualify, and plan the cash for the exercise-stage tax. Handle those well, and your ESOPs deliver their upside without an ugly tax surprise.

Disclaimer: This article is for educational purposes only and is not tax advice. Tax rules change frequently — verify current provisions on the official income tax portal or with a qualified CA before filing.